Jaikanth Chandrasekaran, P. Parasuraman, Panneerselvam Theivendren, K. Sundar, Damodar Nayak Ammunje, Rex Devasahayam Arokia Balaya, Selvaraj Kunjiappan
{"title":"Prospects for repurposing FDA-approved medications as Omicron spike/ACE-2 protein complex disruptors","authors":"Jaikanth Chandrasekaran, P. Parasuraman, Panneerselvam Theivendren, K. Sundar, Damodar Nayak Ammunje, Rex Devasahayam Arokia Balaya, Selvaraj Kunjiappan","doi":"10.29228/jrp.445","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17096,"journal":{"name":"Journal of Research in Pharmacy","volume":"17 1","pages":""},"PeriodicalIF":0.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Research in Pharmacy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29228/jrp.445","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
